Roivant Sciences Ltd. Common Shares (NASDAQ: ROIV) last traded at $35.44, up 3.60% on the session. The quote above updates while this page is open; the figures below are drawn from Roivant Sciences Ltd. Common Shares’s own filings and are restated only when a new one is published.
Roivant Sciences Ltd. Common Shares trades on NASDAQ under the ticker ROIV. Its market capitalisation is $25.60 billion.
Valuation measures for Roivant Sciences Ltd. Common Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $25.60B |
|---|---|
| Enterprise value | $24.74B |
| Price / sales | 3398.72 |
| Price / book | 6.05 |
| Beta | 1.03 |
Trailing-twelve-month figures tagged in Roivant Sciences Ltd. Common Shares's XBRL filings with the SEC.
| Revenue (TTM) | $7.53M |
|---|---|
| Net income (TTM) | -$266.25M |
| EPS (TTM) | -$0.470 |
| Operating margin | -7914.75% |
| Return on equity | -6.29% |
| Cash | $1.25B |
Range and volume for ROIV over the past 52 weeks.
| 52-week high | $42.50 |
|---|---|
| 52-week low | $15.99 |
| Volume | 5.53M |
| Average volume | 7.02M |
| Previous close | $34.21 |
Invest a chosen dollar amount in Roivant Sciences Ltd. Common Shares with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ROIV.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.